Burzynski Research Institute Inc BZYR
$0.01
Last Updated: Aug 18, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Burzynski Research Institute Inc. Stock Analysis BZYR
United States Health Care Nano Cap Burzynski Research Institute, Inc. engages in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the trade name Antineoplastons. The company is headquartered in Houston, Texas and currently employs 0 full-time employees. The company went IPO on 2001-10-15. Antineoplastons are useful in the treatment of human cancer. The firm is reviewing data from its Phase II clinical trials of Antineoplastons relating to the treatment of various cancers. Antineoplastons are found in the bodily fluids of humans and food. The firm conducted all the Phase II clinical trials for the treatment of a variety of cancers using the combination of Antineoplastons A10 and AS2-1. Clinical trials conducted by the Company primarily use intravenous formulations of Antineoplastons, though few trials also use oral formulations. The firm's clinical trials are conducted at the Burzynski Clinic.
Burzynski Research Institute Inc (BZYR) Chart
Financial Metrics & Statements of Burzynski Research Institute Inc (BZYR)
FAQ's for Burzynski Research Institute Inc (BZYR)
- As of August 2026, Burzynski Research Institute Inc BZYR is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Burzynski Research Institute Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Burzynski Research Institute Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Burzynski Research Institute Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Burzynski Research Institute Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Burzynski Research Institute Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Burzynski Research Institute Inc (BZYR)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
